What We Do       Leadership       Therapeutic Areas       Partnering       News       Contact

Board of Directors

Mariano has been appointed to the Board of Directors in November 2018. He has been active at the intersection of healthcare, deal-making and entrepreneurship for over 25 years, experiencing the space from many different angles, be it by building and operating companies, leading M&A and licensing transactions, working for some of the premier players in the business or managing investments for professional equity firms.

He recently stepped down as CEO of GBT, a Latin-American biopharmaceutical company with presence in 10 countries.   At GBT, Mariano launched the company, established the strategy, steered the project through its successive acquisitions and transformations and finally took the company public.  During his career, Mariano worked with investment firms Aqua Capital, Warburg Pincus and Advent International.   He also held several operational positions at Bausch+Lomb in Sao Paulo, Pfizer in New York and in Sao Paulo, McKinsey in Madrid and Eli Lilly in Buenos Aires.

Mariano holds an Engineering degree from Universidad de Buenos Aires and an MBA from the Harvard Business School, for which he earned a Fulbright scholarship.

Stig Pedersen

Executive Chairman

 

Daniel Turner III

Board Member

 

Pascal Forget

Board Member

 

Arthur Higgins

Board Member

 

Mariano Garcia-Valiño

Board Member

 

Joel Barlan

Chief Executive Officer

 


Management Team

 

COPYRIGHT © 2006-2019 MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. THIS INFORMATION—INCLUDING PRODUCT INFORMATION—IS INTENDED ONLY FOR RESIDENTS OF THE UNITED STATES. THE PRODUCTS DISCUSSED HEREIN MAY HAVE DIFFERENT LABELING IN DIFFERENT COUNTRIES.

 

PRIVACY POLICY | LEGAL DISCLAIMER | LINKEDIN | ENGLISH | PORTUGUESE